MDMA-Assisted Therapy for Anorexia in Young Adults
THE MAYA STUDY
We are designing a phase 2, open-label, multi-site clinical trial to investigate the safety, feasibility, and preliminary efficacy of MDMA-assisted therapy in young adults (aged 21–30 years) with anorexia nervosa. The trial will recruit 30 participants from sites in England and the United States, and is anticipated to start in 2027.
Patients
We are NOT recruiting participants for our study at this time. Recruitment is anticipated to start in 202. However, individuals who are interested in participating can join our patient registry
To learn more, click here.
IFS Therapists
We are actively recruiting IFS therapists (Level 1, 2, or 3), ideally with experience treating young people with eating disorders, who are interested in joining our team as a lead or co-therapist.
To learn more, click here.
Sponsors
We are actively seeking $2–3M (USD) from private donors, charities, and organizations to support this trial. All contributions — large or small — advance this critical work.
To learn more, click here.